Literature DB >> 1575248

Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.

K A Yonkers1, J C Kando, J O Cole, S Blumenthal.   

Abstract

OBJECTIVE: This review explores the theoretical background for and empirical evidence supporting gender-related differences in pharmacokinetics and pharmacodynamic properties of psychotropic medications.
METHOD: The authors reviewed all English-language articles on this topic that involved original research using human subjects.
RESULTS: Limited evidence suggests that young women seem to respond better to and require lower doses of antipsychotic agents and benzodiazepines than young men. The administration of exogenous hormones interacts with medications, changing plasma levels and possibly conferring greater risks for toxicity. Young women may have an enhanced response to nontricyclic antidepressants.
CONCLUSIONS: Too little basic and clinical research has been conducted on sex differences in therapeutic effects and side effects of psychopharmacological treatments. Addressing these differences as well as similarities will lead to safer and more effective treatment for all patients.

Entities:  

Keywords:  Biology; Body Weight; Contraception; Contraceptive Methods; Demographic Factors; Diseases; Drug Interactions; Drugs; Family Planning; Literature Review; Menstrual Cycle; Menstruation; Mental Disorders; Metabolic Effects; Oral Contraceptives; Physiology; Population; Population Characteristics; Reproduction; Sex Factors; Treatment

Mesh:

Substances:

Year:  1992        PMID: 1575248     DOI: 10.1176/ajp.149.5.587

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  36 in total

1.  Ethnic differences in the neuroleptic treatment of schizophrenia.

Authors:  P Ruiz; R V Varner; D R Small; B A Johnson
Journal:  Psychiatr Q       Date:  1999

2.  Predictors of treatment response to pharmacotherapy in patients with persistent postural-perceptual dizziness.

Authors:  Sooyeon Min; Ji-Soo Kim; Hye Youn Park
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 3.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

4.  AIDS clinical trials. Is there access for all?

Authors:  L A Lynn
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

Review 5.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

6.  A Psychiatric Residency Curriculum About Gender and Women's Issues.

Authors:  A M Spielvogel; L J Dickstein; G E Robinson
Journal:  Acad Psychiatry       Date:  1995-12

Review 7.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 8.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 9.  Depression in children and adolescents: does gender make a difference?

Authors:  Elizabeth B Weller; Angelica Kloos; Joon Kang; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

Review 10.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.